Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: A case-control study

Thorax

Volumn 70, Issue 12, 2015, Pages 1149-1155

  Madhi, Shabir A ^a,b   Groome, Michelle J ^a   Zar, Heather J ^c   Kapongo, Constant N ^d   Mulligan, Christine ^c   Nzenze, Susan ^a   Moore, David P ^a   Zell, Elizabeth R ^e   Whitney, Cynthia G ^e   Verani, Jennifer R ^e  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; VACCINE;

AGE DISTRIBUTION; ARTICLE; BACTERIAL PNEUMONIA; CASE CONTROL STUDY; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZED CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH AFRICA; SOUTH AFRICAN; VACCINATION; CLINICAL TRIAL; HOSPITALIZATION; MULTICENTER STUDY; PNEUMONIA, BACTERIAL; PRESCHOOL CHILD; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; LOGISTIC MODELS; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, BACTERIAL; SOCIOECONOMIC FACTORS; SOUTH AFRICA; VACCINES, CONJUGATE;

EID: 84957891887     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206593     Document Type: Article

References (18)

1. Walker CL, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013;381:1405-16.
2. Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-8.
3. Cutts FT, Zaman SM, Enwere G, et al.Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005;365:1139-46.
4. Hansen J, Black S, Shinefield H, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J 2006;25:779-81.
5. Fitzwater SP, Chandran A, Santosham M, et al. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediat Infect Dis J 2012;31:501-8.
6. Loo JD, Conklin L, Fleming-Dutra KE, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J 2014;33(Suppl 2):S140-51.
7. CoMMIC. Interim report of the Committee on Morbidity and Mortality in Children under 5 years (CoMMiC):2012. 2012. http://wwwdohgovza%2Fdocs%2Freports%2F2013%2Fmorbidity-%26-mortalitypdf
8. Jones SA, Groome M, Koen A, et al. Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants. PLoS ONE 2013;8:e72794.
9. Madhi SA, Bamford L, Ngcobo N. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme. S Afr Med J 2014;104(3 Suppl 1):228-34.
10. Department of Health. http://www.health-e.org.za/2012/12/11/2011-national-antenatal-hiv-syphilis-prevalence-survey-released/ (accessed 30 Jul 2014).
11. Barron P, Pillay Y, Doherty T, et al. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ 2013;91:70-4.
12. Tregnaghi MW, Saez-Llorens X, Lopez P, et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial. PLoS Med 2014;11:e1001657.
13. Cherian T, Mulholland EK, Carlin JB, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 2005;83:353-9.
14. Dupont WD. Power calculations for matched case-control studies. Biometrics 1988;44:1157-68.
15. Lucero MG, Nohynek H, Williams G, et al. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J 2009;28:455-62.
16. Madhi SA, Kuwanda L, Cutland C, et al. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis 2005;40:1511-18.
17. Madhi SA, Klugman KP. World Health Organisation definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines. Vaccine 2007;25:2413-19.
18. Madhi SA, Kohler M, Kuwanda L, et al. Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia. Pediatr Infect Dis J 2006;25:30-6.